An additional opportunity for PRP is in the treatment of solid tumor masses by the direct injection of PRP into those tumor masses. In order to achieve this, Propanc is developing an injectable form of PRP which would be suitale for direct injection into tumor masses, the intention being to cause shrinkage of individual problematic tumor masses. NEWS QUOTE ~ "We are grateful for the confidence Southridge has shown in Propanc, our management team, and our strategy."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.